Active Ingredient History
Ioxaglic acid (trade name Hexabrix) is an iodine containing molecule used as a low-osmolality contrast medium. Ioxaglic Acid is an ionic tri-iodinated benzoate used as a contrast agent in diagnostic imaging. Like other organic iodine compounds, ioxaglic acid blocks x-rays and appears opaque on x-ray film, thereby enhancing the visibility of structure and organs during angiography, arteriography, arthrography, cholangiography, urography, and computed tomography (CT) scanning procedures. Ioxaglic acid has low osmolarity and is therefore associated with few side effects compared to older contrast agents. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Brain Diseases (approved 1986)
Cerebral Arterial Diseases (approved 1985)
Coronary Artery Disease (approved 1986)
Coronary Vessel Anomalies (approved 1985)
Joint Diseases (approved 1985)
Phlebography (approved 1985)
Renal Insufficiency (approved 1986)
Urinary Tract Infections (approved 1985)
Coronary Artery Disease (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue